Enable your JavaScript to use Numstock


Numstock » AGE

AGE Stock Analysis

The latest metrics for AgeX Therapeutics, Inc

Value

Metric Target Value
Price / Earnings Ratio < 12.0 -4.53
Price / Book Value Ratio < 1.5 12.52
Price / Sales Ratio < 2.0 35.12
PEG Ratio < 1.0 0.0
EV / EBITDA Ratio < 8.0 -4.11
Price / FCF Ratio Last Year < 15.0 -4.82
Price / FCF Ratio Last Quarter < 15.0 -15.56
Price / TBV Ratio Last Year < 0.7 10.64
Price / TBV Ratio Last Quarter < 0.7 26.71
Price / NCAV Ratio Last Year < 0.7 9.31
Price / NCAV Ratio Last Quarter < 0.7 37.74

Efficiency

Metric Target Value
ROE Last Year > 25.0% -101.9
ROE Last Quarter > 25.0% -58.11
ROA Last Year > 15.0% -70.3
ROA Last Quarter > 15.0% -39.36
ROTA Last Year > 20.0% -127.6
ROTA Last Quarter > 20.0% -40.07
ROIC Last Year > 20.0% -541.4
ROIC Last Quarter > 20.0% -189.6
ROCE Last Year > 20.0% -126.9
ROCE Last Quarter > 20.0% -57.1
Inventory Turnover Last Year > 4.0 0.0
Inventory Turnover Last Quarter > 4.0 0.0
Pre-tax Margin Last Year > 20.0% -680.2
Pre-tax Margin Last Quarter > 20.0% -992
Accounts Payable Turnover Last Year > 3.0 2.43
Accounts Payable Turnover Last Quarter > 3.0 0.15
Accounts Receivable Turnover Last Year > 5.0 2.78
Accounts Receivable Turnover Last Quarter > 5.0 0.37

Health

Metric Target Value
Current Ratio Last Year > 1.5 3.22
Current Ratio Last Quarter > 1.5 1.92
Quick Ratio Last Year > 1.5 3.22
Quick Ratio Last Quarter > 1.5 1.92
Flow Ratio Last Year < 1.25 0.47
Flow Ratio Last Quarter < 1.25 0.38
Debt / Equity Ratio Last Year < 0.5 0.0
Debt / Equity Ratio Last Quarter < 0.5 0.04
Debt / EBITDA Ratio Last Year < 4.0 0.0
Debt / EBITDA Ratio Last Quarter < 4.0 -0.02
Debt / NCAV Ratio Last Year < 2.0 0.0
Debt / NCAV Ratio Last Quarter < 2.0 0.13
Long-term Debt / Working Capital Ratio Last Year < 2.0 0.0
Long-term Debt / Working Capital Ratio Last Quarter < 2.0 0.08
Interest Coverage Ratio Ratio Last Year > 8.0 0.0
Interest Coverage Ratio Last Quarter > 8.0 0.0
FCF / Sales Ratio Last Year > 8.0% -574.2
FCF / Sales Ratio Last Quarter > 8.0% -634.8

Growth

Metric Target Value
Earnings Yield > 12% -22.08
Ebit Yield Last Year > 12% -20.59
Ebit Yield Last Quarter > 12% -6.04
FCF Yield Last Year > 10% -14.79
FCF Yield Last Quarter > 10% -4.81
Forward P/E to Trailing P/E Ratio > 1.1 0.0
Operating Cash Flow / EPS Ratio Last Year > 1.2 0.72
Operating Cash Flow / EPS Ratio Last Quarter > 1.2 0.2

Dividends

Metric Target Value
Dividend Yield > 2.0% 0.0
FCF / Dividends Paid Ratio Last Year > 2.5 0.0
FCF / Dividends Paid Ratio Last Quarter > 2.5 0.0
EPS / Dividends Paid Last Year > 2.5 0.0
EPS / Dividends Paid Last Quarter > 2.5 0.0
Payout Ratio < 40.0% 0.0

Ratings

Metric Target Value
Altman Z-score Last Year ≥ 3.5 -9.37
Altman Z-score Last Quarter ≥ 3.5 -11.22